Charles River Laboratories (CRL) Reports Q4 EPS of $0.65, Tops Street By 2c; Affirms FY08 Guidance
Tweet Send to a Friend
Charles River Laboratories, Inc. (NYSE: CRL) reports Q4 EPS of $0.65, 2 cents better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
